In this study, we therefore used comprehensive bioinformatics methods to evaluate GPX4's differential expression in its correlation and pan carcinoma with prognosis, immune cell infiltration and DLBCL diagnosis. This evidence concerns the gene GPX4 and diffuse large B-cell lymphoma.